Skip to main content

Casper Marc N's Form 4 filing

Thermo Fisher Scientific Inc. (TMO) · filed Sep 9, 2025

Accession no.
0000097745-25-000131
Filed
Sep 9, 2025
Trade date
Sep 5, 2025
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $200.2K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Casper Marc NCIK 0001216055Director, Officer (Chairman & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 5, 2025Common StockMOption exerciseAcquired+400$253.99+$101,596114,162.29Direct
Sep 5, 2025Common StockSSaleDisposed−200$500.00−$100,000113,962.29Direct
Sep 5, 2025Common StockSSaleDisposed−100$501.00−$50,100113,862.29Direct
Sep 5, 2025Common StockSSaleDisposed−100$501.01−$50,101113,762.29Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 5, 2025Common StockMOption exerciseDisposed−400$0.00$024,354Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)